Collectively, these evidences demonstrate that RETNLB deficiency suppresses the viability, mobility and invasiveness of oral squamous cell carcinoma cells partly by inactivating the TLR2/4/ERK signaling pathway. This evidence concerns the gene TLR2 and oral cavity squamous cell carcinoma.